India’s rising weight burden is pushing healthcare forward, and Agilus Diagnostics is stepping in with a bold move. The company has rolled out its new obesity test suite, built to give clinicians deeper insight into insulin resistance, metabolic...
Bayer’s investigational MRI contrast agent gadoquatrane is drawing industry attention today after new pediatric data strengthened its safety and performance profile. The company revealed fresh results from its QUANTI Pediatric study at the RSNA...
Drug-maker Lupin said on December 5, 2025, that it has received tentative approval from the US Food and Drug Administration (USFDA) for its generic version of Siponimod Tablets. The approved strengths are 0.25 mg, 1 mg, and 2 mg. These tablets...
.jpeg)
Granules India reported that its subsidiary in the U.S., with step-down operations, Granules Consumer Health, LLC, has passed a Good Manufacturing Practice (GMP) inspection conducted by the U.S. Food and Drug Administration (FDA) with zero observatio
.png)
Ciplostem, launched today by Cipla in partnership with Stempeutics Research, signals a strong move into orthobiologic medicine. The new MSC therapy enters the market as India faces a fast-growing burden of knee osteoarthritis, now affecting more...
Wockhardt Ltd. has made industry history today as the US FDA formally accepted its New Drug Application for Zaynich, marking the first time an Indian pharmaceutical company has achieved NDA acceptance for a New Chemical Entity...
Biotechnology is poised to significantly enhance Maharashtra's health sciences ecosystem, as the state government plans to establish a cutting-edge Life Sciences Innovation and Incubation Centre designed to expedite research and development within
Granules India Limited unveiled the inauguration of two cutting-edge Centres of Excellence at the Technology Research Park of IIT Hyderabad. These comprise the Ascelis Center of Excellence for Peptide Development
Nitin Stephen Abel, Senior Director at Terumo Interventional Systems, Terumo India, engaged in a conversation with Thiruamuthan, Assistant Editor at India Pharma Outlook, discusses India’s rapid evolution in interventional radiology—from diagnostic a
.png)
Lupin has obtained U.S. FDA approval of Armlupeg, a biosimilar of Neulasta. The product is pegfilgrastim 6mg/0.6ml prefilled injection in a single-dose syringe to be used as a subcutaneous injection. The manufacturing will be done in the biotech...
.jpg)
, CDSCO.jpg)